Caroline experienced significant improvement overnight with her oxygen levels, and her lungs were clear when she woke up, so we were able to be discharged this afternoon. The year is already off to a great start!
Next steps: Caroline has clinic appointments, daily shots and numerous oral medications between now and her next admission for Round 4 of Immunotherapy, which is scheduled for mid-January. As always, we will keep you posted on this blog. Thank you so, so much for the continued thoughts and prayers. Happy 2019!
The Lantz Family
#carolinestrong
#ftgf
Nov 2017: Diagnosed with Stage IV high-risk Neuroblastoma. Nov 2017–Apr 2019: Completed standard treatment; NED. Apr 2019–Apr 2021: Completed DFMO clinical trial. Apr 2022: Relapse. Apr 2022–Jun 2023: Completed relapse treatment; NED again. Jun 2023–Jun 2024: High-dose DFMO (compassionate use) clinical trial. Jun 2024: Second relapse. Jul 2025: NED again. Mar 2026: Relapse.
Such great news. Happy New Year to you all
ReplyDelete